UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Adjuvant Trial of Tamoxifen and Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil: Evidence for the Superiority of Treatment With Endocrine Blockade in Premenopausal Patients With Hormone-Responsive Breast Cancer—Austrian Breast and Colorectal Cancer Study Group Trial 5

Journal of clinical oncology, 2002-12, Vol.20 (24), p.4621-4627

2002

Volltextzugriff (PDF)

Randomized Trial of Low-Dose Chemotherapy Added to Tamoxifen in Patients With Receptor-Positive and Lymph Node–Positive Breast Cancer

Journal of clinical oncology, 1999-06, Vol.17 (6), p.1701-1709

1999

Volltextzugriff (PDF)

Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer

Clinical cancer research, 2002-06, Vol.8 (6), p.1831-1837

2002

Volltextzugriff (PDF)

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

Clinical cancer research, 2008-03, Vol.14 (6), p.1767-1774

2008

Volltextzugriff (PDF)

Development of clinical practice guidelines (CPGs): An outline exemplified on recent CPG reviews

European surgery, 2006-02, Vol.38 (1), p.21-26

Steindorfer, P.

2006

Volltextzugriff (PDF)

Randomized Trial of Tamoxifen Versus Tamoxifen Plus Aminoglutethimide as Adjuvant Treatment in Postmenopausal Breast Cancer Patients With Hormone Receptor-Positive Disease: Austrian Breast and Colorectal Cancer Study Group Trial 6

Journal of clinical oncology, 2003-03, Vol.21 (6), p.984-990

2003

Volltextzugriff (PDF)

The affinity of MCF7 breast cancer cells to hyaluronan substrates of different molecular weight and concentrations in an in vitro model

International journal of oncology, 2000-11, Vol.17 (5), p.1019

2000

Volltextzugriff (PDF)

Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer—Subset analysis of the ESPAC‐1 data

International journal of cancer, 2009-06, Vol.124 (12), p.2960-2965

2009

Volltextzugriff (PDF)

Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor–Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy

Clinical cancer research, 2009-09, Vol.15 (18), p.5888-5894

2009

Volltextzugriff (PDF)

The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)

Breast cancer research and treatment, 2008-11, Vol.112 (2), p.309-316

2008

Volltextzugriff (PDF)

Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients

Oncology research and treatment, 2003-04, Vol.26 (2), p.115-119

2003

Volltextzugriff (PDF)

Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy

Clinical cancer research, 2008-04, Vol.14 (7), p.2082-2087

2008

Volltextzugriff (PDF)

Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients

European journal of cancer (1990), 1998-01, Vol.34 (1), p.66-70

1998

Volltextzugriff (PDF)

Ossifying Fibromyxoid Tumour of the Neck Clinically Mimicking a Primary Neoplasm of the Thyroid Gland

Pathology, research and practice, 1995-02, Vol.191 (1), p.57-60

1995

Volltextzugriff (PDF)

Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters

Anticancer research, 1995-03, Vol.15 (2), p.581

1995

Volltextzugriff (PDF)

Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers

Human mutation, 2005-12, Vol.26 (6), p.583-589

2005

Volltextzugriff (PDF)

Editorial

European Surgery, 1997-06, Vol.29 (3), p.109-110

Steindorfer, P. F.

1997

Volltextzugriff (PDF)

Therapeutische Aspekte des duktalen Carcinoma in situ (DCIS) der Brust

European Surgery, 1997-06, Vol.29 (3), p.132-133

1997

Volltextzugriff (PDF)

The impact of progesterone receptor in prediction of complete pathological response to preoperative chemotherapy in primary breast cancer patients: Eur Surg 36: 41–45, 2004

European surgery, 2004-02, Vol.36 (1), p.49-50

2004

Volltextzugriff (PDF)

Results of irradiation treatment in patients with non-resectable oesophageal cancer

European journal of surgical oncology, 1995-12, Vol.21 (6), p.627-631

1995

Volltextzugriff (PDF)

A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer

Oncology, 1994-11, Vol.51 (6), p.518-522

1994

Volltextzugriff (PDF)

Hemostatic Methods for the Management of Spleen and Liver Injuries

World journal of surgery, 1996-10, Vol.20 (8), p.1107-1112

1996

Volltextzugriff (PDF)

Experience with an annular phased array hyperthermia system in the treatment of advanced recurrences of the pelvis

Recent results in cancer research, 1988, Vol.107, p.226

1988

Volltextzugriff (PDF)

Non-functional malignant paraganglioma of the stomach

Virchows Archiv A Pathological Anatomy and Histopathology, 1990-05, Vol.417 (3), p.261-266

1990

Volltextzugriff (PDF)

The influence of trauma on changes in neutrophil granulocyte function assessed by an analysis of granulocyte migration

Langenbecks Archiv fur Chirurgie, 1996, Vol.381 (3), p.148

1996

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Aktive Filter

KollektionThieme Connect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(61)
Deutsch
(23)

Erscheinungsjahr

n.n

Thema

Humans
(43)
Female
(32)
Science & Technology
(30)
Life Sciences & Biomedicine
(28)
Middle Aged
(28)
Aged
(23)
Adult
(22)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Oncology
(21)
Breast Neoplasms - Drug Therapy
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Male
(13)
Antineoplastic Agents
(11)
Chemotherapy
(11)
Fluorouracil - Administration & Dosage
(11)
Pharmacology. Drug Treatments
(11)
Tumors
(11)
Combined Modality Therapy
(10)
Breast Cancer
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Adjuvant Trial of Tamoxifen and Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil: Evidence for the Superiority of Treatment With Endocrine Blockade in Premenopausal Patients With Hormone-Responsive Breast Cancer—Austrian Breast and Colorectal Cancer Study Group Trial 5

Randomized Trial of Low-Dose Chemotherapy Added to Tamoxifen in Patients With Receptor-Positive and Lymph Node–Positive Breast Cancer

Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

Development of clinical practice guidelines (CPGs): An outline exemplified on recent CPG reviews

Randomized Trial of Tamoxifen Versus Tamoxifen Plus Aminoglutethimide as Adjuvant Treatment in Postmenopausal Breast Cancer Patients With Hormone Receptor-Positive Disease: Austrian Breast and Colorectal Cancer Study Group Trial 6

The affinity of MCF7 breast cancer cells to hyaluronan substrates of different molecular weight and concentrations in an in vitro model

Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer—Subset analysis of the ESPAC‐1 data

Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor–Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy

The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)

Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients

Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy

Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients

Ossifying Fibromyxoid Tumour of the Neck Clinically Mimicking a Primary Neoplasm of the Thyroid Gland

Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters

Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers

Editorial

Therapeutische Aspekte des duktalen Carcinoma in situ (DCIS) der Brust

The impact of progesterone receptor in prediction of complete pathological response to preoperative chemotherapy in primary breast cancer patients: Eur Surg 36: 41–45, 2004

Results of irradiation treatment in patients with non-resectable oesophageal cancer

A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer

Hemostatic Methods for the Management of Spleen and Liver Injuries

Experience with an annular phased array hyperthermia system in the treatment of advanced recurrences of the pelvis

Non-functional malignant paraganglioma of the stomach

The influence of trauma on changes in neutrophil granulocyte function assessed by an analysis of granulocyte migration

Aktive Filter

Suchergebnisse filtern